首页 | 本学科首页   官方微博 | 高级检索  
     


Pyridostigmine for treatment of neurogenic orthostatic hypertension
Authors:Paola Sandroni  Tonette L. Opfer-Gehrking  Wolfgang Singer  Phillip A. Low
Affiliation:(1) Autonomic Disorders Center, Mayo Clinic, 200 First Street SW, Rochester (MN), 55905, USA
Abstract:Abstract We report the result of a follow-up, open-label study of pyridostigmine for treatment of orthostatic hypotension. Aim of the study was to evaluate self-reported efficacy and patientsrsquo satisfaction with the medication. Most patients were very satisfied with the medication and chose to continue it.This study was supported in part from grants from the National Institutes of Health, Bethesda, MD: 5 K23 RR15537 (Dr. Sandroni), NS3 2352, NS4 4233 NS4 3364 (Dr. Low), and Mayo GCRC grant M01-RR00585
Keywords:orthostatic hypotension  pyridostigmine
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号